Caroline Brito Nunes examined blood samples and genetic markers from 38,000 women with gestational diabetes and nearly 776,000 without it, asking a question that had long divided the scientific field: Are gestational diabetes and type 2 diabetes two separate diseases, or are they fundamentally the same condition, simply triggered at different times?
The answer, emerging from the University of Queensland's collaboration with the Genetics of Diabetes In Pregnancy Consortium, reshapes how we understand diabetes in pregnancy. The research reveals that gestational diabetes—which affects about 14% of pregnancies—is likely an early manifestation of type 2 diabetes, hastened by the metabolic stress that pregnancy places on the body. This discovery matters because both conditions are becoming increasingly common and straining health systems worldwide, and understanding their true relationship could transform prevention and treatment strategies.
The team identified 37 genetic variants linked to gestational diabetes, seven of which had never been reported before. What proved most striking was the overlap: almost all of these variants were also associated with type 2 diabetes. "We also discovered that some of these variants appear to have stronger effects on diabetes specifically during pregnancy," Brito Nunes explained, hinting that while the diseases share a deep genetic foundation, pregnancy creates a unique metabolic crucible where certain genetic vulnerabilities become activated.
Women with gestational diabetes face an 8- to 10-fold increased risk of developing type 2 diabetes later in life, a statistic that underscores the biological continuity between the two conditions. Professor David Evans captured the significance plainly: gestational and type 2 diabetes are "genetically very similar, with a small genetic component that may be pregnancy specific." In other words, the diseases are cousins more than strangers.
The study's strength lies in its diversity. Researchers included participants from European, East Asian, South Asian, African, and Hispanic backgrounds, making it the most inclusive genetic study of gestational diabetes to date. This breadth allowed the team to detect something crucial: evidence of genuine ancestry-related differences in how genetics influence the condition. Dr. Gunn-Helen Moen noted that genetic effects may vary across populations—a finding that challenges one-size-fits-all approaches to diabetes care and prevention.
The complications of gestational diabetes are serious and immediate: overly large babies, obstructed labor, preterm deliveries, and health risks for both mother and child. Yet this research suggests something more hopeful. By understanding that gestational diabetes is often an early warning sign of type 2 diabetes, clinicians can intervene more strategically during pregnancy and in the years that follow, potentially preventing or delaying the onset of type 2 diabetes through lifestyle modifications and targeted support.
Even as this study closes one chapter, a larger one is opening. A much bigger study involving millions of participants is already underway to further untangle the genetic drivers of gestational diabetes and expand representation across even more diverse populations. The work published in Nature Communications represents not an ending but a foundation—solid evidence that pregnancy can reveal what genetics alone might conceal, and that understanding one condition illuminates the other.